Pentapeptides derived from A beta 1-42 protect neurons from the modulatory effect of A beta fibrils-an in vitro and in vivo electrophysiological study

• Published in: Neurobiology of disease Vol. 18; no. 3; pp. 499 - 508
• Main Authors: Szegedi, V, Fulop, L, Farkas, T, Rozsa, E, Robotka, H, Kis, Z, Penke, Z, Horvath, S, Molnar, Z, Datki, Z, Soos, K, Toldi, J, Budai, D, Zarandi, M, Penke, B
• Format: Journal Article
• Language: English
• Published: 01-04-2005
• ISSN: 0969-9961
• DOI: 10.1016/j.nbd.2004.12.008

Short fragments and fragment analogues of beta-amyloid 1-42 peptide (A beta 1-42) display a protective effect against A beta -mediated neurotoxicity. After consideration of our earlier results with in vitro bioassay of synthetic A beta -recognition peptides and toxic fibrillar amyloids, five pentapeptides were selected as putative neuroprotective agents: Phe-Arg-His-Asp-Ser amide (A beta 4-8) and Gly-Arg-His-Asp-Ser amide (an analogue of A beta 4-8), Leu-Pro-Tyr-Phe-Asp amide (an analogue of A beta 17-21), Arg-Ile-Ile-Gly-Leu amide (an analogue of A beta 30-34), and Arg-Val-Val-Ile-Ala amide (an analogue of A beta 38-42). In vitro electrophysiological experiments on rat brain slices demonstrated that four of these peptides counteracted with the field excitatory postsynaptic potential-attenuating effect of A beta 1-42; only Arg-Val-Val-Ile-Ala amide proved inactive. In in vivo experiments using extracellular single-unit recordings combined with iontophoresis, all these pentapeptides except Arg-Val-Val-Ile-Ala amide protected neurons from the NMDA response-enhancing effect of A beta 1-42 in the hippocampal CA1 region. These results suggest that A beta recognition sequences may serve as leads for the design of novel neuroprotective compounds.